IL2 and chronic kidney disease: Additionally, the proportion of CD4+IFN-γ+IL-2+TNF-α+ tends to increase after a booster dose in HD and KT patients (Figure 3E), suggesting that a booster of mRNA vaccine is important to achieve CD4+ T cell polyfunctional responses in CKD patients.